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With growing experience, the indications for salvage extracorporeal membrane oxygenation continue to expand. We describe
a successful application of extracorporeal support in a polytrauma patient presenting with profound hypothermia, respiratory
failure, and whom was later found to have an intracranial hemorrhage. We advocate the role of salvage therapy even in patients
with complex pathophysiology despite perceived relative or absolute contraindications to extracorporeal support.
1.Introduction
The use of extracorporeal membrane oxygenation (ECMO)
has been shown to be an acceptable intervention for patients
with respiratory failure refractory to optimal ventilator man-
agement [1]. As experience with ECMO grows the indica-
tions for use also broaden. For example, patients with pro-
found hypothermia have been also shown to beneﬁt from
central controlled rewarming with ECMO [2]. Furthermore,
while ECMO has been successfully described in patients
with trauma-induced respiratory failure, these patients have
typically undergone extensive evaluation and primary man-
agement of their injuries. In these patients, ECMO is typi-
cally initiated several days after admission and after a trau-
matic brain injury has been ruled out in part because ECMO
has traditionally been contraindicated in those with central
nervous system injuries [3]. We present the successful early
application of ECMO in a patient who presented with pro-
found hypothermia, acute respiratory failure, and an intra-
ventricular hemorrhage following a motor vehicle accident.
2.Case
Our patient is a 27-year-old male who was found unre-
sponsive after a motor vehicle accident. He was intubated
at the scene and transferred to our institution. Upon arrival
his heart rate (71bpm) and blood pressure were stable
(139/97mmHg). However, he was hypothermic so we were
unable to obtain a peripheral temperature with a combined
respiratory and metabolic acidosis (pH = 7.23, pCO2=
63mmHg, pO2 = 62mmHg on 100% oxygen) and despite
topical warming and mechanical ventilation, he remained
hypothermic (<33C) with worsening acidosis and hypox-
emia (pH = 7.19, pCO2 = 49mmHg, pO2 = 56mmHg, base
excess −10, saturating 82% on assist control, rate = 22,
FI02 = 1.0, PEEP = 15mmHg, and 20,000ng/mL of inhaled
epoprostenol sodium). It was felt that he would potentially
beneﬁt from salvage ECMO. Following systemic hepariniza-
tion (10,000 Units), percutaneous femoral-femoral veno-
veno ECMO was initiated with a 23F inﬂow cannula posi-
tioned in the inferior vena cava and a 21F cannula at the
level of the right atrium using a Medtronic Biomedicus
BP-80 pump and tubing circuit (Minneapolis, MN, USA)
and a Maquet Quadrox D oxygenator (Wayne, NJ, USA).
Initial ﬂows were 4.2liters/min on 100% oxygen. He was
actively warmed to normothermia over 8 hours. Once stable,
he was evaluated for other major injuries. A CT of the
chest suggested a pulmonary contusion with consolidation
consistent with an acute aspiration (Figure 1). A CT scan
of the head showed multiple foci of intraparenchymal2 Case Reports in Surgery
Figure 1: Computed tomography (CT) of the chest demonstrates
extent of acute pulmonary injury.
Figure 2: CT of head demonstrates intraventricular and intrapa-
renchymal blood.
hemorrhagewithintraventricularextension,subduralblood,
right-sided edema, and midline shift (Figure 2). Due to his
unresponsiveness and CT scan ﬁndings, a cerebral intra-
ventricular pressure monitor was placed. A transthoracic
echocardiogram was unremarkable. Bronchoscopy failed to
show any obvious obstruction, just diﬀuse airway edema.
RepeatheadCTonposttraumadays1and5showednointer-
val changes. Forty-eight hours after cannulation, heparin
was started and maintained at 4.0units/kg/hour. Evaluation
of the ECMO circuit every 6–8 hours, despite the absence
of anticoagulation initially, did not show any evidence of
thrombus formation or change in gas exchange eﬃciency
(with post circuit blood gases), and a single oxygenator was
used for the entire duration of therapy. Approximately 96
hours after cannulation, he was taken to the operating room
for ECMO decannulation. Prior to leaving the operating
room on assist control (FI02 = 1.0, PEEP = 12, rate 15), his
arterial blood gas was pH = 7.48, pCO2= 35mmHg, pO2
= 296mmHg, and base excess −1.5. Several days later, he
underwent tracheostomy and feeding tube placement. His
intraventricular monitor was subsequently removed.
On posttrauma day 23, he was transferred to an inpatient
rehabilitation facility. At the time of discharge, he was satu-
rating >95% on room air, grossly neurologically intact
although he had evidence of short-term memory impair-
ment and diﬀuse deconditioning. Twenty days later, he was
discharged home with his family tolerating a regular diet, his
tracheostomy had been removed and was ambulating with
minimal assistance.
3. Discussion
ECMO is an established salvage therapy for profound re-
spiratory failure and has recently been shown to be superior
to conventional ventilator management in such patients
[1]. As experience with extracorporeal circulation grows,
unique applications have been described. The need for sys-
temic anticoagulation has often been contraindicated use
in patients with severe intracranial pathology, and in par-
ticular, recent hemorrhage. However, advances in circuit
and oxygenator technology, such as heparin bonding, have
challenged this concern and cases of ECMO support with
intracranial pathology have been recently described. Given
our recent previous experiences with systemic anticoag-
ulation in patients with signiﬁcant intracranial pathol-
ogy requiring life-saving ECMO [4] and cardiopulmonary
bypass [5, 6], had we known about his intracranial bleed
prior to cannulation, we probably would have altered our
initial dose of heparin slightly (e.g., 5,000 or 7,500 unit
bolus), but we still would have systemically anticoagulated
this patient. While anticoagulation can often be held for
several days once ECMO is initiated, as was done in this
case, unfortunately some initial anticoagulation is necessary
during the initial placement of cannulas to prevent them
fromclotting beforeextracorporealblood ﬂow canbestarted
(as we have observed in previous clinical experiences in
which patients were not anticoagulated during cannulation).
While this initial bolus of heparin could worsen, or even
precipitate, intracranial or body cavity bleeding, such deci-
sions are potentially unavoidable and need to be balanced
against clinical needs for a life-saving intervention. Clearly,
the risks and beneﬁts need to be weighed in such extreme
situations such as this case in which deﬁnitive imaging was
not obtainable due to patient physiologic instability prior to
implementation of ECMO.
The management of patients presenting with profound
hypothermia from environmental exposure is dependent
upon the degree of hypothermia and the physiologic conse-
quences. In mild cases, typically topical warming blankets,
warming of intravenous ﬂuids, and, if intubated, warming
of inhaled oxygen are typically suﬃcient. However, in more
severecases,activecorewarmingwithextracorporealcircuits
has been associated with a >6-fold increase in survival when
the presenting core temperature is <30C [2].Case Reports in Surgery 3
In addition, the use of ECMO for respiratory failure fol-
lowing trauma, either as a consequence of primary causes
such as pulmonary contusions, respiratory failure from fat
embolism from long-bone fractures, and acquired pneumo-
nias or secondary to systemic inﬂammatory syndromes such
as adult respiratory distress syndromes has been described
[7]. While survival rates of >50% have been reported in
this extremely sick and complex patient population, typically
these patients have already undergone extensive evaluation
and preliminary management of their injuries. Furthermore,
central nervous system trauma has been a contraindication
to ECMO therapy [8]. Because CNS injuries contraindicate
systemic anticoagulation, life-saving ECMO might not be
oﬀered in this patient population. Furthermore, delays
in addressing profound hypoxemia while evaluating other
potentialinjuriesmaybecontributetosecondaryanoxicCNS
injuries, potentially result in acute and lethal hemodynamic
complications and additional end-organ failure.
Theuniquenessofourcasewastheearlyimplementation
of ECMO as part of the initial trauma evaluation even before
the secondary evaluation for other injuries could be com-
pleted, for the treatment of not only acute severe hypoxemia
but also to assist in systemic rewarming for hypothermia.
Although our patient was subsequently found to have a
traumatic brain injury with intraventricular hemorrhage, we
were able to maintain ECMO without anticoagulation for
48 hours at which time it was felt that his brain injury had
stabilized to the point in which low-dose anticoagulation
could be safely started. This management hypothesis was
conﬁrmed by lack of progression of his head injury on
serial CT scans and stable intracranial pressures. Although
venoarterialECMOsupportwouldtypicallyrequirefullanti-
coagulationtopreventarterial embolization, anadvantageof
veno-veno support is the ability to manage the circuit with
minimal or no anticoagulation, clearly an advantage in the
polytrauma patient, particularly in those with a potential
coagulopathy from both hypothermia and trauma [9]. While
it can be argued that systemic heparinization might have
precipitated or worsened the head bleed in our patient, we
felt that given the nature of our patient’s presentation and
adhering to the basic “airway breathing circulation” prin-
ciples of resuscitation that stabilizing his oxygenation and
ventilation was our only option prior to proceeding with
further evaluation and management.
4. Conclusions
Extracorporeal membrane oxygenation is an acceptable
therapy for patients with profound respiratory failure and
systemichypothermiasecondarytotrauma.Whenindicated,
therapy should be initiated immediately as a component of
the initial trauma evaluation. Delays in therapy, while other
injuries are deﬁned and managed, may contribute to further
anoxic insults and even death. Such interventions may be
beneﬁcial and should be considered even in patients with
severe intracranial pathology such as traumatic intraventric-
ular hemorrhage.
Disclosure
Dr M. S. Firstenberg is a paid consultant/scientiﬁc advisor
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